These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38194443)
1. Long-Term Clinical Outcomes of the 0.18 Mg Fluocinolone Acetonide Intravitreal Implant Following Local Corticosteroid Burst in Noninfectious Uveitis. Janetos TM; Koreishi A; Goldstein DA Ocul Immunol Inflamm; 2024 Jan; ():1-6. PubMed ID: 38194443 [TBL] [Abstract][Full Text] [Related]
2. Single Institution Experience of Intravitreal 0.18-mg Fluocinolone Acetonide Implant for Noninfectious Uveitis. Reddy AK; Pecen PE; Patnaik JL; Palestine AG Ophthalmol Retina; 2023 Jan; 7(1):67-71. PubMed ID: 35820567 [TBL] [Abstract][Full Text] [Related]
3. The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India. Biswas J; Tyagi M; Agarwal M; Ophthalmol Sci; 2024; 4(1):100403. PubMed ID: 38027419 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients. Studsgaard A; Clemmensen KØ; Nielsen MS Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465 [TBL] [Abstract][Full Text] [Related]
5. Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study. Buhl L; Thurau S; Kern C Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1101-1108. PubMed ID: 36399176 [TBL] [Abstract][Full Text] [Related]
6. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results. Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623 [TBL] [Abstract][Full Text] [Related]
7. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results. Jaffe GJ; Pavesio CE; Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244 [TBL] [Abstract][Full Text] [Related]
8. Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant. Cai CX; Skalak C; Keenan RT; Grewal DS; Jaffe GJ Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1023-1030. PubMed ID: 32114654 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal steroids for macular edema in diabetes. Rittiphairoj T; Mir TA; Li T; Virgili G Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal Fluocinolone 0.19mg Implant in the Management of Chronic Non-Infectious Uveitis: 12-Month Outcomes from a Single Tertiary Centre. Pockar S; Leal I; Chhabra R; Jones NP; Steeples LR Ocul Immunol Inflamm; 2023 Oct; 31(8):1572-1578. PubMed ID: 34124978 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758 [TBL] [Abstract][Full Text] [Related]
20. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis. ; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]